How insurance coverage for IVF affects maternal and infant health
Quantifying the Impact of Insurance Coverage for IVF on Maternal and Infant Health
This study looks at how having insurance for in-vitro fertilization (IVF) affects the health of women and their babies, especially for younger and less wealthy women, to see if insurance helps them get better care and outcomes after childbirth.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10893511 on NIH RePORTER |
What this research studies
This research investigates the effects of insurance coverage for in-vitro fertilization (IVF) on the health outcomes of women and infants. It aims to quantify how having or lacking insurance impacts health care utilization and the likelihood of IVF use, particularly among younger and less affluent women. The study will analyze data to determine if insurance coverage leads to better health outcomes and reduced medical costs after childbirth. By addressing financial barriers, the research seeks to improve access to IVF and its associated health benefits.
Who could benefit from this research
Good fit: Ideal candidates for this research are women experiencing infertility, particularly those who are younger or have lower income levels.
Not a fit: Patients who are not seeking IVF treatment or those who already have comprehensive insurance coverage for fertility treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for women and infants by advocating for better insurance coverage for IVF.
How similar studies have performed: Previous research has indicated that financial support for fertility treatments can lead to improved health outcomes, suggesting that this approach may yield significant insights.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Dupree, James M — University of Michigan at Ann Arbor
- Study coordinator: Dupree, James M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.